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Edited by Veli-Pekka LehtoAbstract KLF5 is a Kruppel-like zinc ﬁnger transcription fac-
tor modulating cell proliferation, diﬀerentiation, cell cycle, apop-
tosis, and angiogenesis. The KLF5 protein undergoes multiple
posttranslational modiﬁcations including phosphorylation, acety-
lation and ubiquitination. We have demonstrated that the KLF5
protein can be ubiquitinated by the WWP1 E3 ubiquitin ligase
and degraded by the proteasome. In this study, we found that
KLF5 protein degradation is blocked by an N-terminal FLAG
tag or a small N-terminal deletion without reducing ubiquitina-
tion and degradation mediated by WWP1. Interestingly, the
N-terminal fragments of KLF5 containing the ﬁrst 237 or 171
amino acids are as unstable as the full length KLF5 protein.
The N-terminal FLAG tag or 19 amino acid deletion also
delayed the degradation of the C-terminal truncated KLF5 pro-
teins. To further understand the mechanism, we generated a ly-
sine-less mutant KLF5(1–171). This mutant is eﬃciently
degraded by the proteasome without ubiquitination in vitro and
in vivo. These ﬁndings suggest that KLF5 protein degradation
by the proteasome could be regulated in a ubiquitin-independent
manner.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Ubiquitination1. Introduction
KLF5 is a Kruppel-like zinc ﬁnger transcription factor
which has been shown to play important roles in cardiovascu-
lar remolding [1] and carcinogenesis [2–5]. KLF5 modulates
multiple cellular processes, such as proliferation [6], diﬀerenti-
ation [7,8], cell cycle [4], and apoptosis [9] through regulating
expression of multiple important target genes including
PDGFa [10], PPARc [8], NF-jB [11], and cyclinD1 [12,4].
Like many transcription factors, KLF5 activity is controlled
at diﬀerent levels including DNA dosage [2,3], mRNA tran-
scription [13,14], and several types of protein posttranslational
modiﬁcation [15–17]. Our previous studies suggest that the
KLF5 protein has a short half-life and is rapidly degraded
by the proteasome partially through a ubiquitin-mediated
pathway [17]. Further investigation revealed that the E3 ubiq-
uitin ligase WWP1 speciﬁcally binds to the KLF5 PY motif
and targets it for ubiquitin-mediated proteolysis [18].*Corresponding author.
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multiple elements. For example, transcription factor Myc pro-
tein degradation is mediated by two diﬀerent destruction do-
mains [19,20]. One is the N-terminal ‘degron’ that signals
Myc ubiquitin-mediated degradation, and the other is the D-
element that targets the Myc protein degradation without
aﬀecting its ubiquitination [20]. When we investigated KLF5
degradation using a FLAG tagged construct, we found that
the KLF5 protein is stabilized by an N-terminal FLAG tag.
To our surprise, protein ubiquitination is not aﬀected. To fur-
ther understand the mechanism, we deleted the N-terminal 19
amino acids of KLF5 and obtained a similar result. These
observations are reinforced by the lysine-less mutant KLF5
(1–171), which is degraded by the proteasome without ubiqui-
tination in vitro and in vivo.
The ubiquitin-proteasome system is the primary proteolysis
machine for abnormal proteins and short half-lived regulatory
proteins. Typically, only proteins conjugated with K48 poly-
ubiquitin chains on internal lysines by their E3 ligaseswill be rec-
ognized by the 26S proteasome and degraded. However,
accumulating evidence also suggests that some proteins can be
degraded by the proteasome without ubiquitination, such as
ornithine decarboxylase (ODC) degradation by antienzyme 1
(AZ1)[21], sterioid receptor coactivator 3 (SRC3) degradation
by REGc[22], and Rb degradation by Mdm2 [23]. Our ﬁndings
demonstrated that KLF5 proteasomal degradation could be reg-
ulated by both ubiquitin dependent and independent manners.2. Materials and methods
2.1. Plasmids constructions
Two FLAG tagged KLF5 constructs, pcDNA3.1-FLAG-KLF5 and
pcDNA3.1-KLF5-FLAG, were described in our previous studies [17].
Two KLF5 mutants with N-terminal deletion, DN119-KLF5-FLAG
and DN162-KLF5-FLAG, were generated from pcDNA3.1-KLF5-
FLAG using PCR-based approaches as described previously [17].
Brieﬂy, one PCR product was generated with a forward primer F1
(5 0-TTGAATTCGGGCAGGTACGTGCGCTC-3 0) (EcoR I site is
underlined) and a reverse primer DN119R (5 0-CCTGCGGCGCCA-
TGGGCACTCGGGGGC-3 0) or DN162R (5 0-GCGCGGGCGCCA-
TGGGCACTCGGGGGC-3 0). Another PCR product was generated
with the forward primer DN119F (5 0-AGTGCCCATGGCGCCG-
CAGGACGAGCC-3 0) or DN162F (5 0-AGTGCCCATGGCGCCC-
GCGCAGGCC-3 0) and the reverse primer R1 (5 0-ATCTAGATCCG-
GTGTATTCAGTAGCTGG-3 0) (Xba I site underlined). These two
PCR products, which overlap partially, were puriﬁed and used as
templates to amplify a full-length PCR product using primers F1
and R1. The new PCR products were digested with EcoR I and Xba
I to prepare the insert, which was used to replace the counterpart in
the pcDNA3-KLF5-FLAG.blished by Elsevier B.V. All rights reserved.
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tein, the PCR products were ampliﬁed with the same forward primer
5 0-TTAAGCTTATGGCTACAAGGGTGCTGAG-30 (the primer
contains a Hind III site) and 5 0-TTGGATCCTTCGGCGGCTGGG-
GCACG-3 0 (the backward primer for 1–19), or 5 0-TTGGATCCTTG-
GGCTGCGCCTGCGGG-3 0 (the backward primer for 1–62). The
backward primers contain BamH I sites. The PCR products were
cloned into the pEGFPN1 vector (Clontech) using Hind III and BamH
I sites.
KLF5(1–237), FLAG-KLF5(1–237), and KLF5(20–237) were gen-
erated from pcDNA3.1-KLF5, pcDNA3.1-FLAG-KLF5, and
pcDNA3.1-DN119-KLF5-FLAG respectively using the same strategy.
Brieﬂy, the parental plasmids prepared from Escherichia coli SCS110
(dam) were digested by Xba I (methylation-sensitive) to release the
C-terminal fragment (238–457 amino acids) of KLF5. After re-ligation
and transformation, the resulting plasmids were conﬁrmed by DNA
sequencing.
A KLF5 mutant with a 6·His tag at the C-terminus, pcDNA3.1-
KLF5(1–171)-His, was generated from the pcDNA3.1-KLF5-FLAG
by PCR using the forward primer F1 and a backward primer 5 0-
TTTCTAGATCAATGGTGATGGTGATGATGGCTGAAAATGG-
CAACAGGTT-3 0. The PCR product was digested with EcoR I and
Xba I, then subcloned into pcDNA3.1. The KLF5(1–171)K0-His
was generated from the pcDNA3.1-KLF5(1–171)-His using both the
QuikChange Multi Site-directed Mutagenesis Kit (Stratagene) and
the PCR based approach. There are seven lysines in KLF5(1–171).
Five mutagenic primers were designed following the manual guideline.
Primer sequences are K1: 5 0-TTCGCGCAGCTCAGGCCGGTGCT-
GG-3 0; K2: 5 0-GAGGAGCTGAGGCACGCGCACCACC-3 0; K3:
5 0-TGTGAAATGGAGAGGTATCTGACACCTCAGC-3 0; K6: 5 0-
CTGGCCTCTACAGATCCCAGAGACC-3 0; and K7: 5 0-CGTAA-
CACACATCAGGACAGAACCTGTTGC-3. These primers were
used to mutate ﬁve lysines into arginines after several rounds of muta-
genesis. Because K4 and K5 are next to each other, we failed to mutate
these two lysines using the site-directed mutagenesis kit. pcDNA3.1-
KLF5(1–171)K0-His was ﬁnished by using a PCR-based approach
as described above. Two new primers 5 0-ATTCCAGAGCATAGAA-
GGTATAGACGAGACAGTGC-3 0 and 5 0-CTCGTCTATACCTTC-
TATGCTCTGGAATTATAGGAAC-3 0 were synthesized for this
purpose in combination with F1 and R1 primers.
2.2. Cell culture and measurement of protein stability
The 22Rv1 prostate cancer cell line was maintained in a RPMI-1640
medium supplemented with 5% fetal bovine serum (FBS), HEPES
(0.1 M), sodium pyruvate (1 mM), sodium bicarbonate (0.15%), glu-
cose (0.45%), and penicillin and streptomycin (1%). 293T cells were
maintained in a DMEM medium supplemented with 5% fetal bovine
serum (FBS), glucose (0.45%), and penicillin and streptomycin (1%).
Plasmids were transfected into the 22Rv1 or 293T cells using the Lipo-
fectamine 2000 reagent following the manufacturer’s manual (Invitro-
gen). Protein stability was measured by pulse chase or cycloheximide
(CHX) chase assays as described in our previous studies [17].
2.3. Detection of protein ubiquitination in vivo
Ubiquitination of the FLAG-tagged protein was detected by Wes-
tern blot after immuno-precipitation (IP) by the FLAG-M2 beads (Sig-
ma) as described in our previous studies [17]. Ubiquitination of the
His-tagged protein was detected by Western blot after IP with nickle
beads (Qiagen) under the denatured condition. Brieﬂy, cells in a 60-
mm dish were collected with a 1 ml lysis buﬀer (10 mM Tris–Cl,
100mM NaH2PO4, 8 M Urea, pH 8.0), and sonicated 5 s on ice. Five
hundred microlitres of protein lysate was incubated with 40 ll nickel
beads overnight at room temperature. After washing three times with
1 ml washing buﬀer (10 mM Tris–Cl, 100 mM NaH2PO4, 8 M Urea,
pH 6.3, 20 mM imidazole), the proteins were resuspended in a 30 ll
3· SDS–PAGE sample buﬀer with 300 mM imidazole, denatured,
and subjected to Western blots.
2.4. Detection of protein ubiquitination and degradation in vitro
KLF5(1–171)WT and the K0 mutant were translated in vitro in the
presence of 35S-methionine (MP) using the TNT Quick Coupled Tran-
scription/Translation Systems (Promega) as described in our previous
study [18]. The S100 Hela degradation kit (BostonBiochem) was used
to detect protein ubiquitination and degradation in a 20 ll systemincluding 10 ll Hela S100, 2 ll 10· ubiquitin, 1 ll Ub-aldehyde, 3ll
35S-labelled protein, 2 ll 10· energy regeneration solution, and 1· buf-
fer (50 mM HEPES, pH 7.4). MG132 (0.5 ll 200 lM) was added into
the negative control reactions. The reactions were incubated at 37 C
for 4 h and stopped by adding a 3· SDS–PAGE sample buﬀer. The
samples were denatured and separated on SDS–PAGE and subjected
to autoradiograph for diﬀerent times.3. Results
3.1. A FLAG tag at the N-terminus but not the C-terminus
protects KLF5 from degradation
KLF5 is a short-lived protein (the half-life is about 2 h) as
reported in our earlier study [17]. However, we found that
the KLF5 protein is dramatically stabilized by an N-terminal
FLAG tag in the 22Rv1 prostate cancer cell line in a pulse
chase assay (Fig. 1A and B). The same results were obtained
by a cycloheximide (CHX) chase experiment (Fig. 1C and
D). We further found that the position of the FLAG tag is very
important for stabilizing the KLF5 protein. As shown in
Fig. 1C and D, the FLAG tag does not aﬀect the KLF5
half-life when it is at the C-terminus. These ﬁndings suggest
that the FLAG tag at the KLF5 N-terminus speciﬁcally aﬀects
KLF5 protein degradation.
We have previously demonstrated that the KLF5 protein is
ubiquitinated and degraded by the proteasome in 22Rv1 pros-
tate epithelial cells [17]. We reasoned that the N-terminal
FLAG tag may stabilize the KLF5 protein through reducing
protein ubiquitination. To test this, we examined KLF5 pro-
tein ubiquitination by Western blot after immunoprecipitation
(IP) under denatured condition. To our surprise, the KLF5
protein with the FLAG tag at the N-terminus (FLAG-
KLF5) was still eﬃciently ubiquitinated (Fig. 1E). Actually,
the protein ubiquitination was even increased slightly
compared to the KLF5 protein with the FLAG tag at the C-
terminus (KLF5-FLAG). Under the same condition, poly-
ubiquitinated HA-Ub did not bind to anti-FLAG antibody
M2 conjugated agarose. Several proteins have been reported
to be stabilized by N-terminal tags. For example, MyoD
[24], Id2 [25], and p21 [26] are stabilized by adding an N-termi-
nal Myc tag. A lysine-free Rpn4 fragment can be stabilized by
adding an N-terminal but not a C-terminal HA tag [27]. Inter-
estingly, ubiquitination of p21 is not aﬀected or even increased
by adding a tag to its N-terminus [26]. Taken together, our
ﬁndings indicate that the N-terminal FLAG may block
KLF5 protein degradation through a novel ubiquitin-indepen-
dent manner.
We previously demonstrated that WWP1 E3 ubiquitin ligase
promotes KLF5 ubiquitin-mediated degradation [18]. To test
whether N-terminal FLAG tag only blocks KLF5 ubiquitin-
independent degradation but not ubiquitin-dependent degra-
dation, we cotransfected FLAG-KLF5 and Myc-mWWP1 into
22Rv1 cells. Indeed, WWP1 still eﬀectively promoted FLAG-
KLF5 degradation such as KLF5-FLAG (Fig. 1F). These
results suggest that KLF5 may have two independent degrada-
tion signals.3.2. A small deletion at the N-terminus protects KLF5 from
degradation
It has been reported that ubiquitin chains attached to the
free N-terminal residue rather than the internal lysine residues
Fig. 1. A FLAG tag at the N-terminus but not the C-terminus of KLF5 blocks protein degradation. (A) The N-terminal FLAG tagged KLF5 shows
a longer half-life than WT KLF5 as determined by pulse chase assays. (B) The quantative results of panel A. (C) A FLAG tag at the N-terminus but
not the C-terminus of KLF5 blocks protein turnover as determined by CHX assays. WT KLF5 is used as a control. 50lg/ml cycloheximide was used
to treat cells for one or two hours. b-Actin serves as a loading control. (D) The quantative results of panel C. (E) An N-terminal FLAG tag does not
reduce KLF5 ubiquitination in 22Rv1 cells. Transfected 22Rv1 cells were treated with 10 lM MG132 overnight before harvest. (F) Myc-mouse
WWP1 decreased the steady-state levels of both KLF5-FLAG and FLAG-KLF5 protein at similar eﬃciency in 22Rv1 cells.
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[28]. This mechanism is named N-terminal ubiquitination. In
addition to adding a tag to the N-terminus, a small deletion
at the N-terminus has also been shown to stabilize MyoD,
Id2, p21 and Rpn4 proteins [24–27]. To determine whether
the KLF5 protein is also degraded through the N-terminal
ubiquitination pathway, we sought to generate two KLF5 mu-
tants with small deletions at the N-terminus (KLF5DN119
and KLF5DN162). We measured the half-lives of these mu-
tants by CHX chase in 22Rv1 cells. As shown in Fig. 2A
and B, we found that KLF5DN119 but not KLF5DN162 be-
comes more stable compared to the wild-type (WT) KLF5.
Furthermore, ubiquitination of KLF5DN1–19 appears not to
be aﬀected (Fig. 2C). Finally, WWP1 also eﬃciently targeted
KLF5DN1–19 for degradation like KLF5-FLAG (Fig. 2D).
These ﬁndings imply that the N-terminus of KLF5 aﬀects
KLF5 protein stability though an ubiquitin-independent path-
way.To further test if the ﬁrst 19 amino acids of KLF5 bear any
suﬃcient degradation signals (degron) for protein degradation,
we fused this 19-amino acid fragment to the N-terminus of the
EGFP protein, which is a stable protein in cells. We found that
neither the 19-amino acid nor the 62-amino acid N-terminal
fragments can target the EGFP protein for degradation
(Fig. 2E). These results suggest that the N-terminal fragment
of KLF5 is essential but not a suﬃcient signal for protein deg-
radation. Other signals from KLF5 may be essential for KLF5
protein degradation.
3.3. KLF5(1–237) and KLF5(1–171) are unstable like the full
length KLF5
We hypothesize that there is another degron at the N-termi-
nal KLF5 protein besides the PY motif (325–328), which has
been demonstrated to recruit the WWP1 E3 ligase for KLF5
ubiquitination. We previously identiﬁed a possible PEST (pro-
line-, glutamate-, aspartate-, serine-, and threonine-rich) se-
Fig. 2. A small N-terminal deletion of KLF5 blocks protein degradation. (A) A 19-amino acid but not 62-amino acid deletion at the N-terminus of
KLF5 extends protein half-life as detected by CHX chase assays. WT KLF5 was used as a control. All three constructs have a FLAG tag at the C-
terminus. An anti-FLAG Ab was used to examine the protein levels. (B) The quantative results of panel A. (C) N-terminal deletions of KLF5 do not
aﬀect protein ubiquitination, as detected by Western blot after immunoprecipitation with the anti-FLAG Ab. Transfected 22Rv1 cells were treated
with 10 lM MG132 overnight before harvest. (D) Myc tagged mouse WWP1 decreased the steady-state levels of both KLF5-FLAG and KLF5
DN119-FLAG protein at similar eﬃciency in 22Rv1 cells. (E) N-terminal fragments fused to N-terminal EGFP can not target EGFP protein for
degradation in 22Rv1 cells as detected by CHX chase assays.
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shown to be proteolysis signals in many proteins [29–31]. To
test whether this PEST motif targets the KLF5 protein for deg-
radation, we generated two KLF5 C-terminus truncated mu-
tants KLF5(1–237) and KLF5(1–171)-His. The PY motif no
longer exists in both mutants because of C-terminal trunca-
tion. The potential PEST sequence is kept in KLF5(1–237)
but deleted in KLF5(1–171). We compared the protein half-
lives by CHX chase. As shown in Fig. 3A and B, both
KLF5(1–237) and KLF5(1–171)-His are still unstable and
their half-lives are very close to WT KLF5. We noticed that
KLF5(1–171)-His may be slightly more stable than KLF5(1–
237). These results suggest that the PEST sequence between
171 and 196 only plays a minor role for KLF5 degradation,
if at all. Therefore, the N-terminal KLF5 might bear a degron
distinct from the PEST sequence. The localization of this deg-
ron may be within the ﬁrst 171 amino acids of the KLF5 pro-
tein.
To further test whether the N-terminal FLAG tag or 19-amino
acid deletion also delay the degradation of C-terminal trun-cated KLF5 like the full length KLF5, we made the constructs
expressing FLAG-KLF5(1–237) and KLF5(20–237). We mea-
sured the protein half-lives by CHX chase in 22Rv1 cells and
found that the N-terminal FLAG tag or deletion of amino
acids 1–19 stabilized the truncated KLF5 protein like the full
length KLF5 (Fig. 3C and D). These ﬁndings suggest that
the same regulatory mechanism may be applied to both WT
and C-terminal truncated KLF5 protein. Thus, the truncated
KLF5 protein is a suitable model for studying KLF5 proteol-
ysis.
3.4. Degradation of KLF5(1–171) does not depend on
ubiquitination in vitro and in vivo
If KLF5 is ubiquitinated at the free N-terminal residue, the
mutation of all internal lysines will not aﬀect KLF5 protein
ubiquitination and degradation. Instead of mutating all 19 ly-
sines in the 457-amino acid KLF5 protein, we sought to mu-
tate 7 lysines into arginines in KLF5(1–171) since this
fragment is as short-lived as the intact KLF5 (Fig. 3). We ﬁrst
examined the protein levels and found that the mutant
Fig. 3. N-terminal KLF5 fragment is unstable like the full length KLF5. (A) KLF5(1–237) and KLF5(1–171)-His are short-lived proteins like the
intact KLF5 as determined by CHX chase assays in 22Rv1. KLF5 and KLF5(1–237) were probed by the anti-KLF5 Ab; and KLF5(1–171)-His was
probed by an anti-His Ab. b-Actin serves as a loading control. (B) The quantative results of panel A. (C) The half-lives of FLAG-KLF5(1–237) and
KLF5(20–237) are longer than KLF5(1–237). Proteins were detected by the anti-KLF5 Ab. (D) The quantative results of panel C (the half-life of
KLF5(1–237) from panel A serves as a control).
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(Fig. 4A) . The steady level of mutant KLF5(1–171)K0 protein
is even lower than WT KLF5(1–171). A proteasome inhibitor,
MG132, signiﬁcantly increased the protein levels for both WT
KLF5(1–171) and mutant KLF5(1–171)K0. We then exam-
ined the protein turnover rates by CHX chase. Consistently,
the half-life of KLF5(1–171)K0 is as similarly short as WT
KLF5(1–171) (Fig. 4B and C). In the presence of MG132, both
proteins were stabilized. These results suggest that the internal
lysines are dispensable for KLF5(1–171) protein proteasomal
degradation in mammalian cells.
We further conﬁrmed these results in vitro. Using in vitro
translated proteins as substrates, we found that both
KLF5(1–171)K0 and WT KLF5(1–171) are degraded in a
Hela S100 cell free system (Fig. 5A). MG132 can partially pro-
tect these proteins from degradation. After a long term expo-
sure, we tried to detect ubiquitinated species; however, both
KLF5(1–171)K0 and WT KLF5(1–171) were not heavily ubiq-
uitinated even in the presence of MG132. We noticed that WT
KLF5(1–171) appears to have some higher molecular species
compared to KLF5(1–171)K0 (Fig. 4D). We replaced Ub with
Me-Ub in the cell free system . The degradation of both pro-
teins was not aﬀected (data not shown). These observations
suggest that KLF5(1–171) may be degraded without ubiquiti-
nation in vitro.
To further conﬁrm this observation, we examined protein
ubiquitination in 293T cells. To sensitize the detection, HA-
Ub was co-over-expressed with KLF5(1–171). Because we at-
tached a 6·His tag to the C-terminus of KLF5(1–171), we
immunoprecipitated the proteins with the nickel beads under
denatured conditions. We steadily detected ubiquitination for
WT KLF5(1–171) but not for KLF5(1–171)K0 under the sameconditions (Fig. 5B). These results clearly indicate that the
KLF5(1–171) protein is degraded in an ubiquitin independent
manner in mammalian cells.
3.5. Discussion
KLF5 is an important transcription factor in embryo devel-
opment, cardiovascular remodeling, and tumorigenesis. Fre-
quent KLF5 expression alteration has been reported in
several types of human cancer including breast, prostate, and
intestine [2,3,12]. Our earlier work showed that the ubiqui-
tin-mediated protein degradation plays an important role in
regulating KLF5 abundance and activity [17,18]. In this study,
we present multiple lines of evidence to support a new regula-
tory mechanism for KLF5 proteasomal degradation in which
ubiquitination is dispensable. First, a FLAG tag at the N-ter-
minus of KLF5 stabilizes protein without decreasing ubiquiti-
nation. Second, a 19-amino acid deletion at the N-terminus of
KLF5 protects protein from degradation without aﬀecting
ubiquitination. Additionally, degradation of KLF5(1–171) by
the proteasome does not depend on internal lysines. Finally,
the lysine-less KLF5(1–171) is degraded by the proteasome
in vitro and in vivo without ubiquitination. Collectively, the
KLF5 protein could be degraded via two independent mecha-
nisms. One is apparently ubiquitin dependent, which is in line
with our earlier ﬁndings [17,18], whereas the other does not in-
volve ubiquitination.
Either adding or removing a few amino acids at the N-termi-
nus of KLF5 stabilizes the protein, implying that KLF5 may
be degraded through a mechanism called the N-terminal ubiq-
uitination because similar phenomena have been observed for
MyoD, Id2, and p21 proteins [24–26]. All these proteins have
been shown to be ubiquitinated at the N-terminal methionine
Fig. 4. Proteasomal degradation of KLF5(1–171) does not require
internal lysines. (A) The lysine-less mutant KLF5(1–171)K0-His is an
unstable protein like WT KLF5(1–171)-His in both 22Rv1 and 293T
cells. The proteasome inhibitor MG132 signiﬁcantly stabilizes both
WT KLF5(1–171)-His and the lysine-less mutant KLF5(1–171)K0-His
proteins. (B) The half-life of the lysine-less mutant KLF5(1–171)K0-
His is similar to that of WT KLF5(1–171)-His in 293T cells. The half-
lives of both proteins were increased by MG132. (C) The quantative
results of panel B.
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interrupts the N-terminal ubiquitination site so that the pro-
tein can no longer be eﬃciently ubiquitinated. To test this
hypothesis on KLF5, we generated a lysine-less mutant
KLF5(1–171). Indeed, this mutant can still be eﬃciently de-
graded by the 26S proteasome. However, we found that theFig. 5. The lysine less mutant KLF5(1–171) is not ubiquitinated. (A) T
proteasome without signiﬁcant ubiquitination in S100 Hela extract. The ubiq
exposure, whereas SE represents short term exposure. (B) The lysine-less mut
His is ubiquitinated in 293T cells. Transfected 293T cells were treated with
proteins were precipitated by nickel beads under the denatured condition asKLF5 lysine-less mutant is no longer ubiquitinated compared
to the wild-type counterpart in mammalian cells. This result is
obviously diﬀerent from those proteins degraded through the
N-terminal ubiquitination. The lysine-less mutants of MyoD
[24], Id2 [25], ERK3 [32], and p21 [32] are still eﬃciently ubiq-
uitinated like their WT version. Therefore, we concluded that
KLF5 degradation is not likely through the N-terminal ubiq-
uitination.
If the ubiquitination is not essential for protein degradation
by the proteasome, the possible mechanism is the protein bind-
ing to the proteasome directly or through other adaptor pro-
teins. For example, SRC3 was shown to directly bind to the
20S proteasome activator protein REGc [22]. The Rb tumor
suppressor was reported to interact with the C8 subunit of
the 20S proteasome in the presence of Mdm2 [23]. The prote-
asomal degradation of ODC is mediated by AZ1 [21]. Whether
or not KLF5 directly binds to proteasomal proteins and how
an N-terminal tag or 19-amino acid deletion aﬀects this proce-
dure is currently unknown. Because we observed that the 62-
amino acid deletion did not change KLF5 protein degradation,
it is tempting to speculate that the small deletion speciﬁcally
changed the protein secondary structure which is essential
for proteasome or other proteins binding.
The degradation of KLF5 transcription factor may not com-
pletely depend on proteasome. Multiple bands with smaller
molecular weights were repeatedly detected by anti-KLF5 anti-
body (data not shown), suggesting that the cleavage by un-
known proteases could contribute to KLF5 proteolysis.
Interestingly, the proteasome inhibitor MG132 almost com-
pletely blocks the degradation of the WT but not lysine-less
KLF5(1–171) (Fig. 4C). Whether the seven mutations (Lys
to Arg) change the cleavage of KLF5(1–171) remain eluci-
dated. These results indicate that the degradation of KLF5 is
complicated.
The physiological signiﬁcance that the KLF5 protein bears
multiple independent regulation pathways for proteasomal
degradation, such as the PY motif mediated ubiquitin-depen-
dent pathway, and the N-terminal amino acids mediated ubiq-
uitin-independent pathway, is currently unknown. Several
other transcription factors have been reported to be degraded
through the 26S proteasome in both an ubiquitin-dependenthe lysine-less mutant KLF5(1–171)K0-His is degraded through the
uitination of WT KLF5(1–171) was indicated. LE represents long term
ant KLF5(1–171)K0-His is not ubiquitinated while WT KLF5(1–171)-
10 lM MG132 overnight before harvest. 6·His tagged KLF5(1–171)
described in Section 2.
1130 C. Chen et al. / FEBS Letters 581 (2007) 1124–1130and -independent manner, such as C-jun [33], p53 [34], and
Myc [20]. It is possible that the KLF5 transcription factor uses
protein degradation to integrate multiple upstream signals and
coordinately regulate target gene expression.
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